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Abstrak 
Staphylococcal scalded skin syndrome (SSSS) menggambarkan spektrum kelainan kulit dengan 
gambaran kulit melepuh superfisial yang disebabkan oleh toksin eksfoliatif Staphylococcus 
aureus yang dapat berasal dari fokus infeksi dari konjungtivitis purulen, otitis media atau 
infeksi nasofaring. Kelainan diawali dengan demam, iritabel, dan makula eritema di kulit 
berwarna kemerahan, nyeri dan menyeluruh dan berkembang menjadi erupsi dan melepuh 
dalam 24 sampai 48 jam. Diagnosis harus dibedakan dari penyakit kulit lainnya seperti 
nekrolisis epidermal toksik, epidermolisis bulosa, eritema multiforme, impetigo akibat 
Streptokokus atau Listeriosis dan luka bakar, yang dapat mempunyai gejala yang sama. 
Prognosis SSSS pada anak biasanya baik dengan angka kematian kurang dari 5%. Kasus 
merupakan serang bayi laki-laki usia 3 bulan yang dirawat di ruang Anak RS M. Djamil dengan 
keluhan utama kulit dan mengelupas sejak 2 hari sebelum rawatan. Hasil kultur kulit, mata 
dan hidung adalah Staphylococcus aureus dan pasien diberikan terapi ampisilin dan 
gentamisin selama tujuh hari. 
Kata kunci: Staphylococcal scalded skin syndrome;bayi;infeksi 
  
Abstract 
Staphylococcal scalded skin syndrome (SSSS) describes a spectrum of superficial blistering skin 
disorders caused by the exfoliative toxins of Staphylococcus aureus that originates from a 
focus of infection that may be a purulent conjunctivitis, otitis media, or occult nasopharyngeal 
infection. It usually begins with fever, irritability, and a generalized, paint, orange-red, 
macular erythema with cutaneous tenderness, and the rash progress from scarlatiniform to a 
blistering eruption in 24 to 48 hours. A diagnosis must distinguish SSSS from other skin 
diseases, such as toxic epidermal necrolysis, epidermolysis bullosa, bullous erythema 
multiforme, Streptococcal impetigo or listeriosis and thermal or chemical burns, all of which 
can manifest with similar symptoms. The prognosis of SSSS in children who are appropriately 
treated is good, with a mortality of less than 5%. A case was a three months old boy 
hospitalized in Pediatric ward M. Djamil hospital with chief complain redness and peeling of 
the skin sinces 2 days before hospitalized. Culture of the skin, eyes and nose was 
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INTRODUCTION 
Staphylococcal scalded skin syndrome 
(SSSS) describes a spectrum of superficial 
blistering skin disorders caused by the 
exfoliative toxins (also known as 
epidermolytic toxins, epidermolysins and 
exfoliatins) of Staphylococcus aureus. Its 
severity varies from localized blisters to 
generalized exfoliation affecting the entire 
body surface.1 SSSS commonly occurs in 
neonates and young children less than 6 
years of age. It is due to lack of antitoxin 
antibodies and due to poor renal excretion 
of the toxins. Currently, the incidence of 
this disease is increasing in all ages. Its 
resistance to conventional antibiotic 
treatment is also a new reality.2,3 The 
incidence is estimated to be 1 to 1.4 cases 
per million inhabitants per year. 
Internationally, the incidence is higher in 
developing countries.4 
SSSS originates from a focus of infection 
that may be a purulent conjunctivitis, otitis 
media, or occult nasopharyngeal infection. 
It usually begins with fever, irritability, and 
a generalized, faint, orange-red, macular 
erythema with cutaneous tenderness. 
Within 24 to 48 hours, the rash progress 
from scarlatiniform to a blistering 
eruption.5 A diagnosis must distinguish 
SSSS from other skin diseases, such as toxic 
epidermal necrolysis, epidermolysis 
bullosa, bullous erythema multiforme, 
Streptococcal impetigo or listeriosis and 
thermal or chemical burns, all of which can 
manifest with similar symptoms.6  
The prognosis of SSSS in children who are 
appropriately treated is good, with a 
mortality of less than 5%. Nevertheless, 
some children will die despite antibiotic 
therapy. In contrast, mortality rates in 
adults are very high, usually due to 
underlying diseases, despite aggressive 
treatment.7 We describe a case of an 
infant, 3 months of age with SSSS and 




A three months old boy was hospitalized in 
Pediatric ward M. Djamil hospital with 
chief complain redness and peeling of the 
skin since 2 days before hospitalized. 
Alloanamnesis from his mother with 
present illness history: redness and 
purulent discharge on both of eyes since 3 
days before hospitalized. Patient suffer 
from low grade fever since 3 days ago, 
intermittent, no shivering and no seizure. 
Redness around mouth, nose, behind ears 
and neck since 2 days ago, and spread into 
extensive area of the body, become 
blistering then peeling starts from the 
mouth since 1 day before hospitalized. 
Patient looked irritable and difficult to 
breastfed since 2 days before hospitalized. 
He breastfeds on demand since birth, 










never got formula milk before. There was 
no vomit, no breathlessness, cold and 
cough. There was no infection and 
excoriation on the mother’s breast and no 
history of applying traditional medicines 
on his skin. There was no history of skin 
infection and consuming any drugs before. 
Urination and defecation was still normal. 
Patient had been brought to midwife 2 
days before hospitalization and got 
paracetamol and amoxicillin. 
Patient never suffered from disease like 
this before and there was no family history 
of similar skin lesions or conjunctivitis. 
Patient was the third sibling of 3 children, 
sectio caesarean delivery due to 
premature rupture of membrane (18 
hours), aterm with birth weight 3850 
grams and birth length 52 cms, directly 
crying. Basic immunization was completed. 
History of growth and development was 
normal. Hygiene and sanitation was good. 
His mother was 37 years old, graduated 
from senior high school, a housewife. His 
father was 40 years old, graduated from 
senior high school, work as an 
entrepreneur. Patient has 2 older brother, 
the oldest was 11 years old and the second 
was 6 years old. Patient and her family live 
in their own home, a permanent house 
with good hygiene and sanitation. 
Patient look moderately ill, alert, blood 
pressure 80/50 mmHg, heart rate 126 
times per minute, respiratory rate 34 times 
per minute, body temperature 38,5 oC, 
body weight 6,5 kgs, body height 62 cms, 
weight for age was 0-(+2) SD (Z score), 
height for age was 0-(+2) SD (Z score), 
weight for height was 0-(+2) SD (Z score), 
well nourished, there was no anemic, no 
icteric, no edema and no cyanotic. Skin was 
warm, turgor was good. There was 
superficial skin exfoliation over the 
forehead, mouth, nose, ear, neck, axilla, 
buttock, upper and lower limb, exposing a 
red moist surface with yellowish squama 
around mouth, nose, eyes, ear, and neck, 
mucous was good, Nicolsky’s sign was 
positive. There was no regional lymph 
enlargement. 
Head was round and symmetric, head 
circumference was 40 cms (normocephal), 
major fontanela was not sunken, eyes 
were not sunken, conjunctiva was not 
anemic, sclera was not icteric, purulent 
secret with edema and hyperemic on both 
of eyes, there were no injection on 
conjunctivae, pupil isochors with diameter 
2mm/2mm, light reflex was positive 
normal. Throat was not hyperemic, oral 
mucous was wet, not hyperemic, there was 
no oral trush. There was no neck rigidity. 
The chest was symmetric, there was no 
retraction, heart: regular rhythm, no 
murmur, lung: bronchovesicular, no rales, 
no wheezing. There was no distension at 
abdominal, liver and spleen was not 
palpable, genitalia: puberty state A1P1G1. 
Extremities was warm with good 











Figure 1. Baby F, at first admission. There 
was superficial skin exfoliation over the 
forehead, mouth, nose, ear, neck, axilla, 
buttock, upper and lower limb, exposing a 
red moist surface with yellowish squama 
around mouth, nose, eyes, ear, and neck. 
 
Laboratory finding: 
Haemoglobin: 11,5 gr/dl; leucocyte: 
21.700/mm3, differential count: 
0/0/0/58/42/0, platelet: 370.000/mm3. 
Random blood glucose was 98 mg/dl, 
sodium was 137 mmol/L, potassium was 
3,7 mmol/L. Urinalisis: albumin (-), 
reduction (-), keton (-), leucocyte 1-2/LPB, 
erytocyte 1-2/LPB. 
 
Patient was diagnosed with Staphylococcal 
scalded skin syndrome and conjunctivitis 
ocular dextra et sinistra and was given 
treatment breastfeed on demand, fluid 
infusion with KaEN 1B 105 cc/kgBW/24 
hours, ampicillin 4x250 mg IV, gentamycin 
2x16 mg IV,paracetamol 75 mg (T >38,5 
°C), compress the skin with normal saline 
and planned to do culture of swab on 
conjunctivae, skin, nasal and throat, and 
blood  culture. 
Patient has been consulted to dermatology 
and venereology department with result 
staphylococcal scalded skin syndrome, and 
consultation to ophthalmology 
department was suspected conjunctivitis 
ocular dextra et sinistra. Patient was given 
ofloxacin eye drop and suggest to do 
culture of secret from the eyes. 
Follow up 2nd day of hospitalization 
Patient still fever, not high, intermittent, 
there was no cold, cough, and 
breathlessness. Patient still difficult to 
breastfed. Defecation and urination were 
normal. Patient still erythematic, 
desquamation around mouth and neck still 
present with yellowish squama, there was 
new lesion on the chest. 
Patient look moderately ill, heart rate 110 
times per minute, respiratory rate 36 times 
per minute, body temperature 37,8 oC. 
Skin was warm, turgor was good. There 
was superficial skin exfoliation over the 
forehead, neck, chest, axilla, buttock, 
upper and lower limb, exposing a red moist 
surface with yellowish squama around 
mouth, nose, eyes, behind ears, neck, and 
chest. Eyes: not hyperemic, secret was 
decreased, no edema. The heart and lung 
were normal. There was no distension at 
abdominal. Extremities was warm with 
good perfusion, there was no edema. 
Therapy were continued, and the patient 
got lanolin anhydrous ointments, applied 
30 minutes before bathing. 
 
3rd until 5th day of hospitalization 
There was no fever, cold, cough, and 
breathlessness. Breastfeeding was good. 
Defecation and urination were normal. 
Desquamation around mouth was 
decrease, squama decrease, there was no 










moderately ill, heart rate 112 times per 
minute, respiratory rate 32 times per 
minute, body temperature 37 oC. Skin was 
warm, turgor was good. There was 
superficial skin exfoliation over the 
forehead, neck, chest, axilla, buttock, 
upper and lower limb, squama on mouth, 
neck and behid ears. The eyes: not 
hyperemic, no secret and edema. The 
heart and lung were normal. There was no 
distension at abdominal. Extremities was 
warm with good perfusion, there was no 
edema. Fluid infusion has been stopped, 
antibiotic therapy were continued. 
Culture of the skin: Staphylococcus aureus, 
resistant to ampicillin and intermediate to 
gentamycin. Culture of swab from eyes: 
Staphylococcus aureus, sensitive to 
ampicillin and gentamycin. Culture of swab 
from nasopharyngeal: Klebsiella spp, 
sensitive to gentamycin and resistant to 
ampicillin. Culture of swab from nose: 
Staphylococcus aureus, sensitive to 
ampicillin and gentamycin. Blood culture 
was negative. Antibiotic was continued for 
seven days. 
 
Figure 2. Baby F, at 5th of hospitalization. 
Skin exfoliation was decrease than before. 
There was no other new skin lession. 
 
 
6th until 8th day of hospitalization 
There was no fever, cold, cough, and 
breathlessness. Breastfed was good. 
Defecation and urination were normal. 
Desquamation on skin was decreased, 
there was no squama and no new lesion on 
the skin. Patient look moderately ill, heart 
rate 118 times per minute, respiratory rate 
32 times per minute, body temperature 
37,2 oC. Skin was warm, turgor was good. 
There was no new skin lession, there was 
skin exfoliation over the axilla, upper and 
lower limb, no squama. The heart and lung 
were normal. There was no distension at 
abdominal. Extremities was warm with 
good perfusion, there was no edema. 
Therapy were continued until seven days, 
and patient was discharge at eighth day. 
The parents and brother was suggested to 
do culture of swab from nose and throat, 












Figure 3. Baby F at discharge. There was no 
new skin lession, there was skin exfoliation 
over axilla, upper and lower limb. 
 
DISCUSSION 
Staphylococcal scalded skin syndrome is an 
acute epidermolysis caused by a 
staphylococcal toxin. SSSS usually presents 
with sore throat and purulent 
conjunctivitis as the source of infection. In 
neonates, the umbilical cord is often the 
source of infection. Within 48 hours the 
patient develops fever, malaise and 
extremely tender erythematous area of 
the face, neck, axilla and perineum then 
develop into large flaccid blisters and 
rapidly rupture, resulting in large areas of 
erosion surrounded by epidermal 
patches.19,21 In this case, patient suffer 
from purulent discharge and low grade 
fever since 3 days before hospitalized 
accompanied with redness around mouth 
and spread into extensive area of the body. 
Peeling starts from the mouth since 1 day 
before hospitalized. Patient looked 
irritable and difficult to breastfed. 
SSSS is primarily a disease of neonate and 
children, and clinical feature vary from 
localized blisters to severe exfoliation 
affecting over 90% of the entire body 
surface. In localized form, characteristic 
fragile, thin-roofed, flaccid bullae are 
formed, which rupture easily to release 
fluid that varies from a thin, cloudy, amber 
liquid to purulent, opaque, white or yellow 
pus.5 In generalized form, SSSS usually 
starts with a swift onset of painful, tender 
and red skin attenuated in flexural and 
periorificial areas. After 24 to 48 hours, 
flaccid blisters and erosions develop and 
large areas of the overlying epidermis 
loosen and peel like a scald which can be 
extended.22 
Physical examination on admission 
revealed the skin lesion initially appeared 
as exfoliation most all over the body, 
exposing a red moist surface with perioral 
desquamation and also in neck. Perioral 
crusting was seen, there is no mucosal 
involvement, Nicolsky sign was positive. 
Nicolsky’s sign is a clinical dermatologic 
sign in which blisters spread easily upon 
application of horizontal, tangential 
pressure to the skin. A positive Nicolsky’s 
sign signifies a separation of epithelial cells 
either from one another or from the 
basement membrane.18 
Several risk factors of SSSS have been 
suggested: poor renal clearance of the 
toxins, low antibody status, 
immunosuppression with 
immunosuppressive drugs and 
malignancy.7,8 In this case, patient was 
well-nourished, got breastfed and never 
suffer from any illness or skin lesion before. 
Jeong Do et al (2010) found that most of 
patients with SSSS were preschool-aged 
children who were relatively healthy and 
they were not immunocompromised, and 
they had no chronic illness or renal 
disease.8 Immunosuppression has been 
shown to increase the risk of developing 
generalized SSSS, while maternal 
antibodies have been shown to protect 
newborns. Anti-toxin antibodies were 










This finding reflect passive maternal 
antibodies, which, in turn, may protect 
newborn. The level of antibody fell to 30% 
in 3 and 24 months of age and then 
increase steadily to 50% in those older 
than 10 years and to 91% in those oleder 
than 40 years.4,7 
Epidemiological studies looking at 
antitoxin antibodies suggest that, in the 
localized form, S. aureus enters the skin 
through a break in the skin barrier (such as 
grazes, atopic dermatitis, or chickenpox) 
and produces the toxin locally, but 
hematogenous spread is limited by the 
presence of antitoxin antibodies. In the 
generalized form, however, the toxin is 
usually produced at a distant site. This may 
be a colonization site (such as the nares, 
eye, umbilicus, groin or wound sites) or an 
infective site (such as pneumonia, 
osteomyelitis or endocarditis). Lack of 
protective antibodies allows the toxin to 
spread through the bloodstream to reach 
the mid-epidermis via dermal capillaries to 
produce generalized exfoliation.7,8 
Renal function is also an important 
determinant in developing SSSS and may 
partly explain why young infant may be 
more susceptible. Poor renal clearance of 
the toxins by infant below 3 months of age 
and adult with impaired renal function is a 
major risk factor for developing SSSS. One-
third of ETA would excrete within 3 hours 
compared to 1/15 of ETA within 3 hours in 
neonates and infants. As consequence, 
toxin levels reach a higher peak in newborn 
and decline slowly.7,8 
Staphylococci may be transmitted by 
multiple routes, including contact with 
infected persons, contact with 
asymptomatic carriers, airborne spread, 
and contact with contaminated object. The 
disease usually follows a localized infection 
of the upper respiratory tract, inner ear, 
conjunctiva or umbilical stump. Of these, 
contact with a person with staphylococcal 
lesions appears to be particularly 
important in the spread of staphylococci.4 
In this case, the disease starts with the 
inflammation of the conjunctivae 
(conjunctivitis) which is a Staphylococcus 
commensal site like umbilicus and axilla. 
The history of previous skin infection or 
contact with skin-infected patients in 
which S.aureus infection was denied. 
Most cases of SSSS are diagnosed on 
clinical grounds, supported by the 
presence of S. aureus in nasal, conjunctiva, 
pharyngeal, umbilical or other swabs. 
Detection of ET is required for diagnosis of 
SSSS.19 Other laboratory investigations are 
required only if the clinical findings are 
equivocal or when outbreaks occur. 
Because the condition is the result of the 
exotoxins which may be produced by 
staphylococci at a distant site, the blister 
fluid in generalized SSSS tends to be sterile, 
although a positive culture can be found in 
3% SSSS in children.14 In this case, diagnosis 
based on clinical manifestation of redness 
and blistering of the skin that suddently 
rupture resulting large erythematous area 
covering by yellowish squama with positive 










presence of S. aureus on skin, nasal, and 
conjunctiva. 
In case where the diagnosis remains 
uncertain, the most useful investigation 
remains a skin biopsy, which is not 
practical in children. In SSSS, the biopsy 
would show mid-epidermal splitting at the 
level of the zona granulose, without 
cytolysis, cell necrosis or any inflammatory 
reaction. The biopsy is particularly useful in 
distinguishing SSSS from erythema 
multiforme/toxic epidermal necrolysis, 
where splitting occurs at the dermo-
epidermal level.1 In this case, we didn’t 
perform skin biopsy since the clinical 
manifestation was clear and support with 
the presence of S. aureus. 
The main differential diagnosis is made 
with toxic epidermal necrolysis (TEN), a 
severe variant of erythema multiforme 
usually related to drugs. The latter is 
characterized by dermal-epidermal 
separation, different from the separation 
in the granular layer of the epidermis seen 
in SSSS, as well as by an intense 
inflammatory infiltrate.21 Unlike SSSS, the 
mucous membrane is almost always 
affected, causing extensive erosions in 
mouth, conjunctiva, trachea, bronchi, 
esophagus and genitalia.7 Other 
differential diagnosis of exfoliative skin 
lesions includes bullous impetigo, 
epidermolysis bullosa, and herpetic 
lesions.13 In patients with bullous impetigo, 
the toxin produces blisters locally at the 
site of infection, whereas in scalded skin 
syndrome, it circulates throughout the 
body, causing blisters at sites distant from 
the infection.23 
Management of SSSS is primarily 
supportive, with careful monitoring of 
electrolyte levels because of the potential 
fluid shifts across the denuded skin. 
Because the unprotected skin is 
susceptible to infection, antiseptic 
measures should be undertaken. Particular 
care must be given to pain management 
since the lesions are often very painful, and 
patients with severe peri-oral involvement 
may require short-term intravenous 
nutrition. Young infants require careful 
observation for dehydration, hypothermia 
and secondary infections.1,24 In this case, 
although patient was irritable and poor 
feeding since 2 days before admission, 
there was no sign of dehydration, and 
electrolyte imbalance. Patient got fluid 
therapy intravenously for 2 days because 
of difficult to breastfed. The other 
complication was also not noted. 
Intravenous antibiotics are administered 
to decrease the Staphylococcal burden. 
Early administration of intravenous 
antibiotics, such as cloxacillin or a 
cephalosporin, results in a good recovery 
within seven to ten days. Intravenous 
penicillinase-resistant, anti-staphylococcal 
antibiotics, supportive skin care, as well as 
fluid and electrolyte management in the 
setting of disrupted skin barrier function, 
will ensure rapid recovery.24 Patient got 
combination of ampicillin and 
aminogligocydes intravenously and this 
antibiotics was continued until 7 days, 










and nose were Staphylococcus aureus, 
sensitive to ampicillin and gentamycin. For 
most skin and skin structure infections, 
empiric antibacterial therapy should be 
directed against the most likely pathogen. 
In most of the patients, antibiotics were 
initiated before the culture and sensitivity 
report and as the children responded to 
the same, antibiotics were continued.25,26 
Penicillin remains the drug of choice if the 
isolate is sensitive to it. Antimicrobial 
combinations have been used to increase 
bactericidal activity or to prevent the 
development of antimicrobial resistance. 
The combination of beta lactams and 
aminoglycocides increases bacterial killing 
in vitro. Ampicillin, commonly known as a 
broad-spectrum penicillin, is a type of 
aminopenicillin, a semisynthetic group of 
β-lactams that were developed for 
effectiveness against both gram-negative 
and gram-positive organisms. The 
mechanisms of action of ampicillin are 
interference with cell wall synthesis by 
attachment to penicillin-binding proteins 
(PBPs), inhibition of cell wall peptidoglycan 
synthesis and inactivation of inhibitors to 
autolytic enzymes.12 
Because the condition is toxin mediated, 
exfoliation usually continues 24 to 48 
hours after starting appropriate antibiotic 
treatment, although new lesions are 
uncommon after this period. There have 
been several cases of methicillin-resistant 
S. aureus causing SSSS and this must be 
considered if the patient is not responding 
to empiric antibiotic treatment. In most 
cases, the skin lesions heal rapidly over the 
next 7 to 10 days and because of 
exfoliation is superficial, scarring is rare.1,8 
In this case, the new lesion still present on 
the second day, and exfoliation still found 
until patient was discharge. 
The use of topical agents to treat 
superficial skin infections can limit 
exposure to systemic agents and deliver 
high drug concentrations to the site of 
infection. In this case, patient only got 
lanolin anhydrous and never got topical 
antibiotic. Antibiotic or antiseptic 
ointments should also not applied on large 
areas of the skin in generalized SSSS 
because of systemic toxicity by absorption 
of antibiotics, especially in neonates or 
infants.21 It is also not effective, since the 
focus of infection is usually not known and 
often distant from the site of blistering.17,21 
Skin care generally consists of bland 
emollients (petroleum jelly) and minimal 
handling of patients. Muporicin can be 
used at foci of infection. Gentle cleansing 
may help prevent secondary infection. 
Removal of dried skin with bathing is not 
necessary initially when the skin is too 
tender to touch but is used an adjunct 
later.17 Severe periorbital lesion was 
managed with eye ointments containing 
antibiotics. Patient got lanolin anhydrous 
as emollients and used 30 minutes before 
bathing. 
The prognosis of SSSS is usually good in 
children and is more guarded in infants. 
Complications include sepsis, secondary 
infections, electrolyte imbalance, fluid 
losses and hypothermia. The mortality rate 










patients respond rapidly to treatment, 
with complete recovery within 2 to 3 
weeks. Because the cleavage plane in SSSS 
is superficial, lesions heal without 
scarring.17 In this case, under treatment, 
erythema and exfoliation decrease within 
7 days and was completely healed after 2 
weeks of follow up, with the disappearance 
of the inflammatory syndrome and total 
body surface restored. 
Any patient developing SSSS should be 
immediately isolated. Anyone else at risk 
of developing SSSS who may have been 
exposed to ET-producing S. aureus strains 
should be rapidly identified. 
Unfortunately, a rapid diagnostic kit for 
SSSS is not yet available. Microbiology 
investigation from nose and throat take 
longer time and couldn’t determine ET-
producing S. aureus strains. There was lack 





SSSS is more commonly seen in neonates 
and young children less than 6 years of age. 
It is due to lack of antitoxin antibodies and 
due to poor renal excretion of the toxins. 
The clinical features of SSSS vary along a 
spectrum. The localized form often 
presents with a few localized fragile 
superficial blisters filled with colorless to 
purulent fluid. In generalized form patients 
often initially present with fever and 
erythema, with constitutional symptom 
such as malaise, poor feeding and 
irritability, followed by large superficial 
blisters that quickly rupture, particularly in 
areas of friction. The diagnosis of SSSS is 
mainly based on clinical appearance, and it 
is confirmed by the isolation of S. aureus 
from foci of infection, such as from the 
nose, conjunctivae, umbilicus, or 
nasopharynx, or the exfoliative toxin (ET) 
and/or the histopathological findings.3,17 
Nikolsky’s sign is a clinical dermatologic 
sign in which blisters spread easily upon 
application of horizontal, tangential 
pressure to the skin. The treatment of SSSS 
should aim at eradicating S. aureus, which 
usually requires intravenous antibiotics. 
Penicillin remains the drug of choice if the 
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